Orletto Announces Receipt for its Amended and Restated Prospectus

QUÉBEC CITY, QUÉBEC--(Marketwired - April 24, 2017) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Benoit Chotard, President of Orletto Capital Inc. ("Orletto" or the "Corporation") (TSX VENTURE:OLE.P), a Capital Pool Company, is pleased to announce that it has obtained a receipt for its amended and restated prospectus dated April 21, 2017 amending and restating the amended and restated prospectus dated January 31, 2017 amending and restating the prospectus dated October 27, 2016 (the "Amended Prospectus") in connection with a proposed offering of units of the Corporation for minimum aggregate gross proceeds of $4,000,000 and maximum aggregate gross proceeds of $10,000,000 (the "Offering"), at a price of $0.75 per unit. The Offering will be conducted on a commercially reasonable basis through Richardson GMP Limited. The completion of the Offering forms part of Orletto's intended qualifying transaction whereby Orletto intends to amalgamate with Devonian Health Group Inc. to form an entity to be named "Devonian Health Group Inc./Groupe Santé Devonian Inc."

The Amended Prospectus was filed for the purpose of reducing the minimum offering from $6,000,000 to $4,000,000. The Offering will come to an end no later than on April 26, 2017 and is subject to certain customary conditions and regulatory approvals. The TSX Venture Exchange (the "TSXV") has conditionally approved the transaction and the listing of the resulting issuer subordinate voting Shares. Listing is subject to the Corporation fulfilling all of the requirements of the TSXV.

The Offering is being made pursuant to a prospectus filed in Québec, Ontario, Alberta and British Columbia. A copy of the Amended Prospectus is available on SEDAR at www.sedar.com.

This press release does not constitute an offer of securities for sale in the United States or to "U.S. persons" ("U.S. persons"), as such term is defined in Regulation S promulgated under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"). The securities being offered have not been, nor will be, registered under the U.S. Securities Act or any state securities laws, and may not be offered or sold in the United States or to U.S. persons absent registration or an applicable exemption from such registration requirements.